Merck & Co Inc (MRK)
128.81
-0.41
(-0.32%)
USD |
NYSE |
May 01, 16:00
128.80
-0.01
(-0.01%)
After-Hours: 20:00
Merck Research and Development Expense (TTM): 30.25B for March 31, 2024
Research and Development Expense (TTM) Chart
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 30.25B |
| December 31, 2023 | 30.53B |
| September 30, 2023 | 24.68B |
| June 30, 2023 | 25.77B |
| March 31, 2023 | 15.25B |
| December 31, 2022 | 13.55B |
| September 30, 2022 | 12.84B |
| June 30, 2022 | 10.89B |
| March 31, 2022 | 12.41B |
| December 31, 2021 | 12.25B |
| September 30, 2021 | 14.97B |
| June 30, 2021 | 15.87B |
| March 31, 2021 | 13.63B |
| December 31, 2020 | 13.43B |
| September 30, 2020 | 10.04B |
| June 30, 2020 | 9.898B |
| March 31, 2020 | 10.00B |
| December 31, 2019 | 9.724B |
| September 30, 2019 | 9.538B |
| June 30, 2019 | 8.402B |
| March 31, 2019 | 8.487B |
| December 31, 2018 | 9.752B |
| September 30, 2018 | 9.853B |
| June 30, 2018 | 12.20B |
| March 31, 2018 | 11.71B |
| Date | Value |
|---|---|
| December 31, 2017 | 10.34B |
| September 30, 2017 | 12.81B |
| June 30, 2017 | 10.06B |
| March 31, 2017 | 10.43B |
| December 31, 2016 | 10.26B |
| September 30, 2016 | 7.272B |
| June 30, 2016 | 7.108B |
| March 31, 2016 | 6.627B |
| December 31, 2015 | 6.705B |
| September 30, 2015 | 7.19B |
| June 30, 2015 | 7.349B |
| March 31, 2015 | 7.343B |
| December 31, 2014 | 7.18B |
| September 30, 2014 | 6.732B |
| June 30, 2014 | 6.733B |
| March 31, 2014 | 7.17B |
| December 31, 2013 | 7.503B |
| September 30, 2013 | 7.892B |
| June 30, 2013 | 8.15B |
| March 31, 2013 | 8.214B |
| December 31, 2012 | 8.169B |
| September 30, 2012 | 8.364B |
| June 30, 2012 | 8.40B |
| March 31, 2012 | 8.171B |
| December 31, 2011 | 8.467B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
8.402B
Minimum
Jun 2019
30.53B
Maximum
Dec 2023
15.20B
Average
13.14B
Median
Research and Development Expense (TTM) Benchmarks
| Amgen Inc | 4.784B |
| Johnson & Johnson | 15.30B |
| Eli Lilly and Co | 9.313B |
| Pfizer Inc | 10.68B |
| Moderna Inc | 4.845B |